Genocea Biosciences Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Genocea Biosciences (GNCA) Collaboration with Janssen Can Spark a Bigger Partnership - Stifel
January 4, 2022 10:14 AM ESTStifel analyst Benjamin J. Burnett reiterates a "Buy" rating on shares of Genocea Biosciences (NASDAQ: GNCA), following announcement of collaboration and option agreement with Janssen Biotech, Inc., one... More



